DelSiTech Ltd and C-Tri Co. Ltd Sign a Collaboration Agreement to Develop Innovative Drug Delivery Technology Product for Oncology admin@delsitech.com2018-03-28T07:56:12+02:00December 18th, 2017| Read More
DelSiTech Featured in a Recent Ocular Drug Delivery Business Report admin@delsitech.com2018-02-28T19:41:12+02:00August 22nd, 2017| Read More
DelSiTech and Bayer Partner to Develop Innovative Drug Delivery Technology for Ophthalmology admin@delsitech.com2018-03-28T07:56:42+02:00September 29th, 2016| Read More
DelSiTech now also in social media – the Company Facebook pages launched admin@delsitech.com2018-03-26T10:04:22+02:00May 30th, 2016| Read More
DelSiTech features in the April 2016 edition of Pharma Technology Focus Magazine admin@delsitech.com2018-03-26T10:11:50+02:00April 25th, 2016| Read More
DelSiTech promotes Cora Griffin to Director, Head of Business Development admin@delsitech.com2018-03-26T10:19:05+02:00February 9th, 2016| Read More
DelSiTech’s Silica Matrix for Ocular Delivery featured in ONdrugDelivery admin@delsitech.com2018-03-26T10:31:03+02:00February 2nd, 2016| Read More
DelSiTech receives EU funding from Horizon 2020 programme admin@delsitech.com2018-03-27T09:07:35+02:00October 14th, 2015| Read More
DelSiTech Ltd publishes an animated video on its drug delivery technology admin@delsitech.com2018-03-27T09:47:27+02:00June 15th, 2015| Read More
DelSiTech Ltd enters licensing agreement with Solani Therapeutics Ltd in animal health admin@delsitech.com2018-03-28T07:56:54+02:00May 26th, 2015| Read More